MST1 kinase inhibitor and use thereof
US12318398B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2019 |
| Grant date | Jun 3, 2025 |
| Priority date | — |
| Expiry date | Oct 5, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D475/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a kinase inhibitor, comprising a compound of formula (I) or a pharmaceutically acceptable salt, solvate, ester, acid, metabolite, or prodrug thereof. Also disclosed are a pharmaceutical composition comprising the kinase inhibitor and uses and methods for inhibiting the activity of one or more tyrosine kinases selected from MST1 and a mutant thereof in a cell or subject and for preventing or treating a disease related to MST1 or a mutant thereof in a subject by using the compound or composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.